Valued Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.6K Buy
79
+3
+4% +$1.03K 0.01% 158
2026
Q1
$26.8K Buy
76
+14
+23% +$4.99K 0.01% 148
2025
Q4
$20.4K Buy
62
+6
+11% +$1.9K 0.01% 158
2025
Q3
$15.8K Hold
56
0.01% 178
2025
Q2
$15.6K Buy
56
+5
+10% +$1.42K 0.01% 168
2025
Q1
$16K Buy
51
+1
+2% +$295 0.01% 175
2024
Q4
$13.1K Sell
50
-14
-22% -$4.15K 0.01% 197
2024
Q3
$20.7K Buy
64
+9
+16% +$2.94K 0.01% 143
2024
Q2
$17.3K Buy
55
+4
+8% +$1.18K 0.01% 141
2024
Q1
$14.5K Buy
51
+42
+467% +$12.3K 0.01% 149
2023
Q4
$2.42K Buy
+9
New +$2.45K ﹤0.01% 282

Other funds holding AMGN

Valued Wealth Advisors's AMGN Position: Q2 2026 in Review

Valued Wealth Advisors increased its Amgen (AMGN) stake by 3.9% in Q2 2026, buying an estimated $1.03K and bringing the position to 79 shares worth $28.6K. The position accounts for 0.01% of the portfolio, ranked #158.

Valued Wealth Advisors first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Valued Wealth Advisors held 79 shares of Amgen worth $28.6K as of Q2 2026.
  • Valued Wealth Advisors bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #158 holding.
  • Valued Wealth Advisors first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.